MS Speaks
Multiple Sclerosis => TREATMENTS => TYSABRI (natalizumab) => Topic started by: agate on September 03, 2019, 04:24:52 pm
-
From JAMA Neurology (September 3, 2019)--"Progressive multifocal leucoencephalopathy incidence and risk stratification among natalizumab users in France" (link to entire article):
http://bit.ly/2lYjCt6